Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)

China flag China · Delayed Price · Currency is CNY
32.12
+0.50 (1.58%)
Apr 30, 2026, 3:04 PM CST
22.32%
Market Cap 2.42B
Revenue (ttm) 234.84M
Net Income (ttm) 21.90M
Shares Out 76.49M
EPS (ttm) 0.29
PE Ratio 110.44
Forward PE n/a
Dividend 0.26 (0.82%)
Ex-Dividend Date May 29, 2025
Volume 1,476,330
Average Volume 2,118,741
Open 29.59
Previous Close 31.62
Day's Range 29.59 - 32.43
52-Week Range 26.00 - 36.98
Beta 0.57
RSI 57.31
Earnings Date Apr 29, 2026

About SHE:301130

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sales of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anemia, mental disorders, anti-psychotic disorders, cardiovascular and cerebrovascular diseases, and tumors. It provides drugs in the form of tablets and capsules. The company was founded in 1990 and is headquartered in Panshi, China. [Read more]

Sector Healthcare
Founded 1990
Employees 320
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301130
Full Company Profile

Financial Performance

In 2025, SHE:301130's revenue was 234.84 million, a decrease of -8.41% compared to the previous year's 256.41 million. Earnings were 21.90 million, a decrease of -45.62%.

Financial Statements

News

There is no news available yet.